Cancer Immunotherapy Symposium
Part of the CSCO 2014 Annual Conference
Saturday, September 20, 2014
2:30pm-6:00pm
Xiamen International Conference Center
Xiamen, China
A Joint Symposium by the Society for Immunotherapy of Cancer (SITC), Chinese American Hematologist and Oncologist Network (CAHON), United States Chinese Anti-Cancer Association (US CACA), and the Chinese Society of Clinical Oncology (CSCO)
Shu-Kui Qin, MD (CSCO) - Jiangsu Nanjing Jingdu Hospital
Bernard A. Fox, PhD (SITC) - Earle A. Chiles Research Institute
Wen-Ru Song, MD, PhD (CAHON) - Astra-Zeneca
Bernard A. Fox, PhD (SITC) - Earle A. Chiles Research Institute
Jon Wigginton, MD (SITC) - MacroGenics
Laurence J.N. Cooper, MD, PhD (US CACA) - University of Texas, MD Anderson Cancer Center
Myung-Ju Ahn, MD (US CACA) - Samsung Medical Center, Sungkyunkwan University School of Medicine
Wenru Song, MD, PhD (CAHON) - Astra-Zeneca
Ke Liu, MD, PhD (CAHON) - U.S. Food and Drug Administration
CSCO Representative
CSCO Representative
Oral Abstract Presenter
The full conference was held September 17-21, 2014. The theme of the conference was "to enhance the specification level, expanding the international perspective." CSCO upheld the fundamental purpose of the General Assembly, to further promote international and domestic academic exchanges and scientific cooperation in the field of clinical oncology, clinical research and to encourage and support innovation, promote the standardization of comprehensive treatment, and actively promote academic development.
For more information about the CSCO 2014 Annual Conference, visit: http://reg.csco.org.cn/